Domizia V.
- Country
- Italy
- Department
- SCDU Neurologia
Research Overview
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Teriflunomide in Adults with Relapsing Multiple Sclerosis
- A Randomized, Double-Blind Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
- Phase 3 Randomized, Double-Blind Study of Frexalimab (SAR441344) Versus Placebo in Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 55 of 197 partner sites.
Specializations
Multiple Sclerosis Research
This clinical investigator specializes in studying therapeutic approaches for multiple sclerosis, with particular emphasis on both relapsing and progressive forms of the disease.
- Relapsing Multiple Sclerosis Management
- Secondary Progressive Multiple Sclerosis Treatment
- Novel Therapeutic Interventions
The investigator's work encompasses evaluation of innovative treatments including BTK inhibitors and monoclonal antibodies for MS therapy.
Neurological Therapeutics
Focus areas include the investigation of advanced therapeutic agents for neurological disorders, particularly in progressive neurological conditions.
- Disease Progression Analysis
- Disability Management Strategies
- Comparative Treatment Efficacy
The research encompasses evaluation of treatments targeting neuroinflammatory processes and disease progression mechanisms.
Clinical Outcomes
Expertise in assessing therapeutic outcomes in autoimmune neurological conditions, with focus on measuring disease activity and treatment response.
- Relapse Rate Assessment
- Safety Profile Evaluation
- Long-term Treatment Outcomes
The investigator specializes in comparing therapeutic efficacy of various immunomodulatory treatments in neurological disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.